Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 12—December 2004
Research

Nonsusceptibility of Primate Cells to Taura Syndrome Virus

Carlos R. Pantoja*Comments to Author , Solangel A. Navarro*, Jaime Naranjo*, Donald V. Lightner*, and Charles P. Gerba*
Author affiliations: *University of Arizona, Tucson, Arizona, USA

Main Article

Table

Mean TSV quantification in tissue cell culture mediaa,b

Cell type Source of inoculum Inoculum type Mean viral quantification (viral copies/μL) postexposure
Day 0 Day 4 Day 7
BGMK Hemolymph TSV-infected 2.7 x 106 2.4 x 105 2.5 x 104
SPFc 0 0 0
Hepatopancreas TSV-infected 1.2 x 104 5.0 x 103 5.0 x 103
SPF 0 0 0
FrhK-4 Hemolymph TSV-infected 1.3 x 105 1.9 x 104 4.7 x 103
SPF 0 0 0
Hepatopancreas TSV-infected 1.3 x 104 8.4 x 103 3.7 x 103
SPF 0 0 0
MA-104 Hemolymph TSV-infected 1.5 x 105 3.1 x 104 2.3 x 103
SPF 0 0 0
Hepatopancreas TSV-infected 1.2 x 104 1.3 x 104 9.2 x 103
SPF 0 0 0

aEstimated by real time reverse transcription–polymerase chain reaction at different intervals postexposure.
bBGMK, Buffalo green monkey kidney; FrhK-4, monkey Rhesus female kidney embryonic; MA-104, monkey African green kidney; TSV; Taura syndrome virus; SPF, specific pathogen free.
cInoculum originated from SPF penaeid shrimp.

Main Article

Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external